BTAI position history
The shares of Bioxcel Therapeutics (BTAI) that OAKTREE CAPITAL MANAGEMENT LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q2: 241,188 shares, $437K, <0.01% of portfolio, New
- 2025 Q3: 241,188 shares, $617K, <0.01% of portfolio
- 2025 Q4: 241,188 shares, $386K, <0.01% of portfolio
- 2026 Q1: 482,376 shares, $646K, 0.01% of portfolio, Add +100.0%
- 2026 Q2: 1,380,248 shares, $1.9M, 0.03% of portfolio, Add +186.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|